In this study, two-layer poly(vinyl alcohol)/gelatin
(PVA/GEL)
nanofiber patches containing cinnamaldehyde (CA) in the first layer
and gentamicin (GEN) in the second layer were produced by the electrospinning
method. The morphology, chemical structures, and thermal temperatures
of the produced pure (PVA/GEL), CA-loaded (PVA/GEL/CA), GEN-loaded
(PVA/GEL/GEN), and combined drug-loaded (PVA/GEL/CA/GEN) nanofiber
patches were determined by scanning electron microscopy (SEM), Fourier
transform infrared spectroscopy, and differential scanning calorimetry,
respectively. Their mechanical properties, swelling and degradation
behavior, and drug release kinetics were investigated. SEM images
showed that both drug-free and drug-loaded nanofiber patches possess
smooth and monodisperse structures, and nanofiber size increase occurred
as the amount of drug increased. The tensile test results showed that
the mechanical strength decreased as the drug was loaded. According
to the drug release results, CA release ended at the 96th hour, while
GEN release continued until the 264th hour. The antibacterial and
antibiofilm activities of PVA/GEL, PVA/GEL/CA, PVA/GEL/GEN, and PVA/GEL/CA/GEN
nanofiber patches against Pseudomonas aeruginosa and Staphylococcus aureus were evaluated.
Results showed that PVA/GEL/GEN and PVA/GEL/CA/GEN nanofiber patches
have excellent antibacterial and antibiofilm activities. Moreover,
all materials were biocompatible, with no cytotoxic effects in the
mammalian cell model for 8 days. PVA/GEL/GEN nanofiber patches were
the most promising material for a high cell survival ratio, which
was confirmed by SEM images. This research aims to develop an alternative
method to stop and treat the rapid progression of bacterial keratitis.
In this study, a dental membrane scaffold was fabricated using a 3D printing technique, and the antimicrobial effect of pomegranate seed and peel extract were investigated. For the production of the dental membrane scaffold, a combination of polyvinyl alcohol, starch, and pomegranate seed and peel extracts was used. The aim of the scaffold was to cover the damaged area and aid in the healing process. This can be achieved due to the high antimicrobial and antioxidant content of pomegranate seed and peel extracts (PPE: PSE). Moreover, the addition of starch and PPE: PSE improved the biocompatibility of the scaffold, and their biocompatibility was tested using human gingival fibroblast (HGF) cells. The addition of PPE: PSE into the scaffolds resulted in a significant antimicrobial effect on S. aureus and E. faecalis bacteria. Moreover, different concentrations of starch (1%, 2%, 3% w/v) and pomegranate peel and seed extract (3%, 5%, 7%, 9%, and 11% PE v/v) were analyzed to obtain the ideal dental membrane structure. The optimum starch concentration was chosen as 2% w/v due to it giving the scaffold the highest mechanical tensile strength (23.8607 ± 4.0796 MPa). The pore sizes of each scaffold were studied by SEM analysis, and pore sizes were arranged between 155.86 and 280.96 μm without any plugging problems. Pomegranate seed and peel extracts were obtained by applying the standard extraction method. High-performance liquid chromatography was performed using the diode-array detection (HPLC-DAD) technique to analyze the phenolic content of the pomegranate seed and peel extracts. Two phenolic components of the pomegranate seed and peel extracts were investigated in the following amounts: fumaric acid (17.56 μg analyte/mg extract) and quinic acid (18.79 μg analyte/mg extract) in pomegranate seed extract and fumaric acid (26.95 μg analyte/mg extract) and quinic acid (33.79 μg analyte/mg extract) in pomegranate peel extract.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.